Live Attenuated Influenza Vaccine
Sponsors
University of Rochester, Patricia L. Hibberd, McMaster University, National Center for Occupational Health and Infection Control, Imperial College London
Conditions
HealthyImpact of VaccinationInfluenzaInfluenza PreventionInfluenza Vaccines Efficacy and SafetyVaccine Virus Shedding
Phase 1
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
CompletedNCT01545349
Start: 2012-02-29End: 2013-05-31Updated: 2017-01-11
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519
Start: 2021-09-20End: 2022-03-30Target: 160Updated: 2021-09-24
Phase 4
Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants
TerminatedNCT01194297
Start: 2010-08-31End: 2012-05-31Updated: 2014-08-22
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
CompletedNCT01246999
Start: 2010-10-31End: 2013-06-30Updated: 2016-12-29
Live Versus Inactivated Influenza Vaccine Study in Hutterite Children
CompletedNCT01653015
Start: 2012-11-30End: 2015-12-31Updated: 2018-10-26
Efficacy & Safety of Nasal Influenza Immunisation in Children
CompletedNCT02549365
Start: 2015-10-31End: 2016-04-30Updated: 2019-12-11
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years
CompletedNCT03101462
Start: 2011-02-24End: 2011-11-09Updated: 2019-03-06
Revealing Protective Immunity to Influenza Using Systems Immunology
CompletedNCT06501963
Start: 2024-10-14End: 2025-04-01Updated: 2026-03-30
Intranasal LAIV Mucosal Immunity Examination
Not yet recruitingNCT07093281
Start: 2026-02-28End: 2026-07-31Target: 25Updated: 2025-12-19
The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study
RecruitingNCT07240922
Start: 2025-10-01End: 2030-10-01Target: 600Updated: 2025-12-09